These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15863000)

  • 1. 5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors.
    Matulenko MA; Lee CH; Jiang M; Frey RR; Cowart MD; Bayburt EK; Didomenico S; Gfesser GA; Gomtsyan A; Zheng GZ; McKie JA; Stewart AO; Yu H; Kohlhaas KL; Alexander KM; McGaraughty S; Wismer CT; Mikusa J; Marsh KC; Snyder RD; Diehl MS; Kowaluk EA; Jarvis MF; Bhagwat SS
    Bioorg Med Chem; 2005 Jun; 13(11):3705-20. PubMed ID: 15863000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.
    Matulenko MA; Paight ES; Frey RR; Gomtsyan A; DiDomenico S; Jiang M; Lee CH; Stewart AO; Yu H; Kohlhaas KL; Alexander KM; McGaraughty S; Mikusa J; Marsh KC; Muchmore SW; Jakob CL; Kowaluk EA; Jarvis MF; Bhagwat SS
    Bioorg Med Chem; 2007 Feb; 15(4):1586-605. PubMed ID: 17197188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.
    Perner RJ; Lee CH; Jiang M; Gu YG; Didomenico S; Bayburt EK; Alexander KM; Kohlhaas KL; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2803-7. PubMed ID: 15911258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors.
    Gomtsyan A; Didomenico S; Lee CH; Stewart AO; Bhagwat SS; Kowaluk EA; Jarvis MF
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4165-8. PubMed ID: 15261263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor.
    Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS
    J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.
    Hamby JM; Connolly CJ; Schroeder MC; Winters RT; Showalter HD; Panek RL; Major TC; Olsewski B; Ryan MJ; Dahring T; Lu GH; Keiser J; Amar A; Shen C; Kraker AJ; Slintak V; Nelson JM; Fry DW; Bradford L; Hallak H; Doherty AM
    J Med Chem; 1997 Jul; 40(15):2296-303. PubMed ID: 9240345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
    Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
    J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridopyrimidine analogues as novel adenosine kinase inhibitors.
    Zheng GZ; Lee C; Pratt JK; Perner RJ; Jiang MQ; Gomtsyan A; Matulenko MA; Mao Y; Koenig JR; Kim KH; Muchmore S; Yu H; Kohlhaas K; Alexander KM; McGaraughty S; Chu KL; Wismer CT; Mikusa J; Jarvis MF; Marsh K; Kowaluk EA; Bhagwat SS; Stewart AO
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2071-4. PubMed ID: 11514141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.
    Perner RJ; Gu YG; Lee CH; Bayburt EK; McKie J; Alexander KM; Kohlhaas KL; Wismer CT; Mikusa J; Jarvis MF; Kowaluk EA; Bhagwat SS
    J Med Chem; 2003 Nov; 46(24):5249-57. PubMed ID: 14613327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.
    Wiesner JB; Ugarkar BG; Castellino AJ; Barankiewicz J; Dumas DP; Gruber HE; Foster AC; Erion MD
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1669-77. PubMed ID: 10336567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Gfesser GA; Bayburt EK; Cowart M; DiDomenico S; Gomtsyan A; Lee CH; Stewart AO; Jarvis MF; Kowaluk EA; Bhagwat SS
    Eur J Med Chem; 2003 Mar; 38(3):245-52. PubMed ID: 12667691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Cowart M; Lee CH; Gfesser GA; Bayburt EK; Bhagwat SS; Stewart AO; Yu H; Kohlhaas KL; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Alexander KM; Jarvis MF; Kowaluk EA
    Bioorg Med Chem Lett; 2001 Jan; 11(1):83-6. PubMed ID: 11140740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.
    Gomtsyan A; Didomenico S; Lee CH; Matulenko MA; Kim K; Kowaluk EA; Wismer CT; Mikusa J; Yu H; Kohlhaas K; Jarvis MF; Bhagwat SS
    J Med Chem; 2002 Aug; 45(17):3639-48. PubMed ID: 12166937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
    Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
    J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats.
    Radek RJ; Decker MW; Jarvis MF
    Brain Res; 2004 Nov; 1026(1):74-83. PubMed ID: 15476699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis.
    Bauser M; Delapierre G; Hauswald M; Flessner T; D'Urso D; Hermann A; Beyreuther B; De Vry J; Spreyer P; Reissmüller E; Meier H
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1997-2000. PubMed ID: 15050645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.
    Muchmore SW; Smith RA; Stewart AO; Cowart MD; Gomtsyan A; Matulenko MA; Yu H; Severin JM; Bhagwat SS; Lee CH; Kowaluk EA; Jarvis MF; Jakob CL
    J Med Chem; 2006 Nov; 49(23):6726-31. PubMed ID: 17154503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.
    Bookser BC; Matelich MC; Ollis K; Ugarkar BG
    J Med Chem; 2005 May; 48(9):3389-99. PubMed ID: 15857145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.